Literature DB >> 4146996

Determination of salicylazosulphapyridine in biological materials.

M Sandberg, K A Hansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4146996

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN： 0001-6675


× No keyword cloud information.
  12 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.

Authors:  G O Cowan; K M Das; M A Eastwood
Journal:  Br Med J       Date:  1977-10-22

3.  The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.

Authors:  A K Azad Khan; M Nurazzaman; S C Truelove
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

4.  Placental and mammary transfer of sulphasalazine.

Authors:  A K Khan; S C Truelove
Journal:  Br Med J       Date:  1979-12-15

5.  Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).

Authors:  P A van Hees; J H Tuinte; J M van Rossum; J H van Tongeren
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

6.  The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors:  A K Azadkhan; S C Truelove; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

7.  The metabolism of salicylazosulphapyridine in ulcerative colitis: II The relationship between metabolites and the progress of the disease studied in outpatients.

Authors: 
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

8.  Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine.

Authors:  V Gupta; J P Jani; S Jacobs; M Levitt; L Fields; S Awasthi; B H Xu; M Sreevardhan; Y C Awasthi; S V Singh
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Authors:  R P Chan; D J Pope; A P Gilbert; P J Sacra; J H Baron; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

10.  Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.

Authors:  A K Azad Khan; D T Howes; J Piris; S C Truelove
Journal:  Gut       Date:  1980-03       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.